Marksans Pharma Limited MARKSANS.NS · Stock Open Marksans Pharma Limited in new tab
Marksans Pharma Limited Analysis (MARKSANS.NS)
Is Marksans Pharma Limited a good investment? Marksans Pharma Limited (MARKSANS.NS) is currently trading at 269.10 INR. Market analysts have a consensus price target of 266.00 INR. This suggests the asset is currently trading above analyst expectations.
In terms of valuation, the stock trades at a P/E ratio of 28.08. This valuation is generally in line with the broader market.
Earnings Schedule: Marksans Pharma Limited is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 13.50.
For income investors, Marksans Pharma Limited pays a dividend yield of 0.35%. With a payout ratio of 9%, the dividend appears sustainable.
Investor FAQ
Does Marksans Pharma Limited pay a dividend?
Yes, it pays an annual dividend of 0.90 INR (0.35% yield).
What asset class is Marksans Pharma Limited?
Marksans Pharma Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 9.21.
Company Profile
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.90 INR
|
| Sept. 10, 2026 | 0.9000 |
| ▸2025 |
0.80 INR
|
| Aug. 21, 2025 | 0.8000 |
| ▸2024 |
0.60 INR
|
| Oct. 5, 2024 | 0.6000 |
| ▸2023 |
0.50 INR
|
| Sept. 27, 2023 | 0.5000 |
| ▸2022 |
0.25 INR
|
| Sept. 28, 2022 | 0.2500 |
| ▸2021 |
0.25 INR
|
| Oct. 23, 2021 | 0.2500 |
| ▸2020 |
0.10 INR
|
| Oct. 29, 2020 | 0.1000 |
| ▸2019 |
0.05 INR
|
| Oct. 26, 2019 | 0.0500 |
| ▸2018 |
0.05 INR
|
| Oct. 27, 2018 | 0.0500 |
| ▸2017 |
0.05 INR
|
| Oct. 26, 2017 | 0.0500 |
| ▸2016 |
0.12 INR
|
| Oct. 29, 2016 | 0.1200 |
| ▸2015 |
0.12 INR
|
| Oct. 29, 2015 | 0.1200 |
| ▸2014 |
0.10 INR
|
| Oct. 25, 2014 | 0.1000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Marksans Pharma Limited | Sep 10, 2026 | Upcoming | 0.9 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| March 11, 2008 | 10.000000 |
Community Discussion